The origin of oncogenic mutations: where is the primary damage?

Area of Science:

• Oncology
• Cancer Biology
• Epidemiology

Background:

• The traditional cancer model posits initiation from a single cell with critical gene mutations due to DNA damage.
• This single-hit paradigm struggles to explain epidemiological observations like cancer's age dependence and lower-than-expected incidence in hereditary mutation carriers.
• Specific oncogenic mutations (e.g., TP53) are common in certain cancers, yet hereditary carriers do not show a commensurate increase in incidence.

Purpose of the Study:

• To re-evaluate the prevailing model of cancer initiation in light of epidemiological data.
• To propose an alternative hypothesis where multi-cellular processes, rather than single-cell mutations, are rate-limiting in common cancers.

Main Methods:

• Theoretical analysis integrating existing epidemiological data with cancer biology.
• Hypothesis formulation based on inconsistencies between genetic mutation prevalence and cancer incidence rates.

Main Results:

• Epidemiological data are inconsistent with the single-hit mutation theory as the sole driver of cancer incidence.
• The incidence of many cancers appears to be governed by rate-limiting processes involving large numbers of cells.
• Hereditary mutations in tumor suppressor genes do not fully predict cancer risk, suggesting other factors are involved.

Conclusions:

• Mutations in key genes like TP53 may be important but not necessarily the rate-limiting events in common carcinogenesis.
• A hypothesis is proposed where neoplastic transformation arises from a local collapse of intercellular regulatory processes.
• This collapse, potentially due to widespread genetic or environmental factors affecting tissue integrity, could trigger a cascade of mutations.